{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-24-008699","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.538748+00:00","generated_at":"2026-06-02T06:21:16.306523+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alzamend Neuro dismisses Baker Tilly as auditor, appoints Haskell & White","bullets":["Audit Committee dismissed Baker Tilly US, LLP on May 5, 2024; no accounting disagreements.","Baker Tilly's 2023 audit report included a going-concern explanatory paragraph.","Material weakness in internal control over financial reporting existed in FY 2022 and 2023.","Haskell & White LLP appointed as new independent auditor for fiscal year 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-24-008699","json":"https://secwatch.observer/filing/0001214659-24-008699.json","markdown":"https://secwatch.observer/filing/0001214659-24-008699.md","text":"https://secwatch.observer/filing/0001214659-24-008699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924008699/0001214659-24-008699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924008699/r582408k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:21:16.306523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"825801c9441efa81276ce7f233778452548c7149","claim":"Alzamend Neuro, Inc. dismissed Baker Tilly US, LLP as its auditor.","evidence_excerpt":"̈ Item 4.01 Changes in Registrant’s Certifying Accountant (a) Dismissal of Previous Independent Registered Public Accounting Firm On May 5, 2024, the Audit Committee (the “ Audit Committee ”) of the Board of Directors of Alzamend Neuro, Inc. (the “ Company ”) dismissed Baker Tilly US, LLP (“ Baker Tilly ”) as the Company's independent registered public accounting firm, effective","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924008699/0001214659-24-008699-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Baker Tilly US, LLP"},{"label":"Successor","value":"Haskell & White LLP"}]},{"claim_id":"a572dcfad0439915565a4cdc381d7a82246a9232","claim":"Alzamend Neuro, Inc. engaged Haskell & White LLP as its auditor.","evidence_excerpt":"On May 5, 2024, the Audit Committee approved the engagement of Haskell & White LLP","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924008699/0001214659-24-008699-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Haskell & White LLP"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}